NK Cell definition

NK Cell means natural killer cell.
View Source
NK Cell means a natural killer cell, or an innate lymphocyte that does not express a TCR, and recognizes target cells through a balance of signals from activating and inhibitory receptors. For clarity, NK Cells do not include T Cells. NK cells may express CD56 and CD16.
View Source

Examples of NK Cell in a sentence

  • Exhibit 1.23 is a true and complete list of all Patents Controlled by GCLC or any GCLC Affiliate as of the Effective Date that relate to methods and tools for culturing or engineering NK Cells, NK Cells produced by such methods (including NK Cells containing CARs and NK Cells with other receptor or marker modifications), NK Cell manufacturing and production methods or cryoformulation technologies.

  • All NantKwest NK Cell Therapy IP made or conceived by Viracta and/or its employees, agents or contractors (either solely or jointly with others) shall be promptly and fully disclosed to NantKwest and all right, title and interest therein are hereby assigned and shall be assigned by Viracta to NantKwest without charge to NantKwest.

  • Prior to the Effective Date, FATE entered into certain agreements under which FATE has been granted licenses in relation to iPSC-derived NK cell technology subject to Third Party payment obligations that are set forth on Exhibit A (“FATE NK Cell Agreements”).

  • All the terms “T Cell Biology” in Sections [***] and [***] of the Agreement shall be replaced by “T and NK Cell Biology” and the Joint Development Plan set forth on Exhibit 1.69 shall also include activities directed to NK Cell Biology, as applicable.

  • Thereafter, upon ONO’s exercise of the ONO Option with respect to a CAR-targeted NK therapeutic, such FATE NK Cell Agreements shall be deemed Existing Agreements under the Agreement and such Patents shall be added to the Agreement as FATE Patents and sublicensed to ONO with respect to such CAR-targeted NK therapeutic, effective upon such ONO Option exercise relating thereto.

  • Any and all data, ideas, suggestions, discoveries, applications, uses, inventions, technology, know-how, trade secrets and other intellectual property relating primarily to NK Cell Therapy or to Products, that are made or conceived by either party or their employees, agents or contractors (either solely or jointly with others) during the performance of research and development activities conducted under this Agreement (“NantKwest NK Cell Therapy IP”) shall be the property of and owned by NantKwest.

  • AFMD is a biotechnology company that is engaged in research and development of NK Cell engaging antibody technology pharmaceutical products.

  • For the avoidance of doubt, FCDI is given no right under this Article 8 to be CENTURY’s (a) clinical suppler, exclusive or otherwise, of NK Cell Products or T Cell Products outside of the scenarios described in this Article 8, or (b) commercial supplier, preferred or otherwise, of NK Cell Products or T Cell Products, and CENTURY shall retain full rights to manufacture and supply NK Cell Products and T Cell Products in commercial form itself or through a third party contracting manufacturing organization.

  • FATE hereby represents and warrants to ONO, as of the Amendment 01 Effective Date, that the Patents set forth on Exhibit B of this Amendment 01 (FATE NK Cell Patents) are Controlled by FATE or its Affiliates in connection with the Research, Development and Commercialization of any CAR-targeted NK cell therapeutics.

  • Senti Biosciences has requested GeneFab to provide a Statement of Work for the Technology Transfer and cGMP production of Senti Bio’s manufactured intermediate (NK Cell CD3-CD56+ Enrichment) to support Phase I clinical programs.